Global COPD Drugs Market Forecast to 2023 COPD Market Report | Page 18

List of Figures
Figure No.
Figure Title
Page No.
Figure 121: U.K COPD Drugs Market, By Value, 2013-2017 (USD Million) 117
Figure 122: U.K COPD Drugs Market, By Value, 2018-2023(USD Million) 117
Figure 123: Germany, COPD Prevalence, 2013-2017, 2018E-20123E, (in Millions) 118
Figure 124: U.K, Health Expenditure, (% of GDP), 2013-2017 (USD) 119
Figure 125: U.K, Population Ages 65 and Above (% of total), 2012-2017 119
Figure 126: U.K, Population Ages 65 and Above (% of total), 2012-2017 119
Figure 127: U.K, Spending on Healthcare, 2015 & 2040, (USD Per Person) 119
Figure 128: UK, PM2.5 air pollution, mean annual exposure (micrograms per cubic meter), 2012-2017 120
Figure 129: UK, Smoking Prevalence (% of Total), 2012-2017 120
Figure 130: U.K COPD Drugs Market Size, By Drug Type, 2017 (%) 121
Figure 131: U.K COPD Drugs Market Size, By Drug Type, 2023F (%) 121
Figure 132: U.K COPD Drugs Market, By Drug Type, By Value, 2013-2017 (USD Million) 122
Figure 133: Italy COPD Drugs Market, By Value, 2013-2017 (USD Million) 124
Figure 134: Italy COPD Drugs Market, By Value, 2018-2023(USD Million) 124
Figure 135: Germany, COPD Prevalence, 2013-2017, 2018E-2023E, (in Millions) 125
Figure 136: Italy, Health Expenditure, (% of GDP), 2013-2017 (USD) 126
Figure 137: Italy, Population Ages 65 and Above (% of total), 2012-2017 126
Figure 138: Italy, Healthcare Infrastructure Related Statistics 126
Figure 139: Italy, Spending on Healthcare, 2015 & 2040, (USD Per Person) 126
Figure 140: Italy, Smoking Prevalence, Age 15+, 2012-2016 127
(c) AZOTH Analytics
18